BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2022 6:17:12 AM | Browse: 317 | Download: 496
Publication Name World Journal of Clinical Oncology
Manuscript ID 65123
Country Türkiye
Received
2021-02-28 11:06
Peer-Review Started
2021-02-28 11:13
To Make the First Decision
Return for Revision
2021-04-27 03:59
Revised
2021-05-05 18:58
Second Decision
2021-12-16 03:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-12-23 05:57
Articles in Press
2021-12-23 05:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-12-13 01:55
Typeset the Manuscript
2022-01-17 13:18
Publish the Manuscript Online
2022-01-22 06:17
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Role of radiotherapy in oligometastatic breast cancer: Review of the literature
Manuscript Source Invited Manuscript
All Author List Caglayan Selenge Beduk Esen, Melis Gultekin and Ferah Yildiz
ORCID
Author(s) ORCID Number
Caglayan Selenge Beduk Esen http://orcid.org/0000-0001-9967-8177
Melis Gultekin http://orcid.org/0000-0002-1806-2619
Ferah Yildiz http://orcid.org/0000-0002-2557-8103
Funding Agency and Grant Number
Corresponding Author Caglayan Selenge Beduk Esen, MD, Research Scientist, Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Altındağ, Ankara 06100, Türkiye. selengebedk@gmail.com
Key Words Breast cancer; Oligometastatic; Radiotherapy; Locoregional treatment; Ablative therapy; Metastasis-directed therapy
Core Tip Radiotherapy (RT) has been traditionally used for only palliation of the symptoms caused by metastatic lesions. However, in recent years the concept of oligometastatic disease has been introduced in Cancer Medicine as a clinical scenario with a limited number of metastases (≤ 5) and involved organs (≤ 2) with controlled primary tumor. The main hypothesis in oligometastatic disease is that locoregional treatment of primary tumor site and metastasis-directed therapies with surgery and/or RT may improve outcomes. The current review will provide up-to-date information about the role of RT in oligometastatic breast cancer.
Publish Date 2022-01-22 06:17
Citation Beduk Esen CS, Gultekin M, Yildiz F. Role of radiotherapy in oligometastatic breast cancer: Review of the literature. World J Clin Oncol 2022; 13(1): 39-48
URL https://www.wjgnet.com/2218-4333/full/v13/i1/39.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i1.39
Full Article (PDF) WJCO-13-39.pdf
Full Article (Word) WJCO-13-39.docx
Manuscript File 65123_Auto_Edited-ZMG-Filipodia.docx
Answering Reviewers 65123-Answering reviewers.pdf
Audio Core Tip 65123-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 65123-Conflict-of-interest statement.pdf
Copyright License Agreement 65123-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 65123-Language certificate.pdf
Peer-review Report 65123-Peer-review(s).pdf
Scientific Misconduct Check 65123-CrossCheck.png
Scientific Misconduct Check 65123-Bing-Gong ZM-2.png
Scientific Editor Work List 65123-Scientific editor work list.pdf